Advertisement
Screener

Stoke Therapeutics, Inc. (STOK) ROA

Stoke Therapeutics, Inc. (STOK) ROA

  • 2026-06-30: ROA -52.77%.
  • 2026-03-31: ROA -38.30%.
  • 2025-12-31: ROA -1.65%.
  • 2025-09-30: ROA 11.26%.

Complete source-backed roa history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-52.77%
2026-03-31-38.30%
2025-12-31-1.65%
2025-09-3011.26%
2025-06-3013.65%
2025-03-3112.36%
2024-12-31-32.77%
2024-09-30-35.95%
2024-06-30-33.65%
2024-03-31-52.89%
2023-12-31-45.85%
2023-09-30-43.10%
2023-06-30-40.86%
2023-03-31-35.12%
2022-12-31-39.47%
2022-09-30-35.97%
2022-06-30-31.96%
2022-03-31-29.65%
2021-12-31-35.92%
2021-09-30-29.92%
2021-06-30-25.34%
2021-03-31-20.79%
2020-12-31-17.54%
2020-09-30-23.93%
2020-06-30-20.34%
2020-03-31-17.04%
2019-12-31-14.13%
2019-09-30-11.07%
2019-06-30-8.59%
2018-12-31-11.64%

Annual ROA

DateROA
2025-12-31-1.65%
2024-12-31-32.77%
2023-12-31-45.85%
2022-12-31-39.47%
2021-12-31-35.92%
2020-12-31-17.54%
2019-12-31-14.13%
2018-12-31-11.64%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82
Eton Pharmaceuticals, Inc. (ETON)United States$1.701B80.74
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Innoviva, Inc. (INVA)United States$1.493B4.62
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Xencor Inc (XNCR)United States$1.776B-7.33
Septerna, Inc. (SEPN)United States$1.783B-63.01